Yuetiva Deming

3.9k total citations
40 papers, 1.3k citations indexed

About

Yuetiva Deming is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Yuetiva Deming has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 20 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Yuetiva Deming's work include Alzheimer's disease research and treatments (23 papers), Genetic Associations and Epidemiology (13 papers) and Bioinformatics and Genomic Networks (10 papers). Yuetiva Deming is often cited by papers focused on Alzheimer's disease research and treatments (23 papers), Genetic Associations and Epidemiology (13 papers) and Bioinformatics and Genomic Networks (10 papers). Yuetiva Deming collaborates with scholars based in United States, Germany and Sweden. Yuetiva Deming's co-authors include Carlos Cruchaga, Laura Piccio, Jorge L. Del‐Aguila, David M. Holtzman, Anne M. Fagan, Marc Suárez‐Calvet, Estrella Morenas‐Rodríguez, Christian Haass, John Q. Trojanowski and Michael Ewers and has published in prestigious journals such as Human Molecular Genetics, Science Translational Medicine and PLoS Genetics.

In The Last Decade

Yuetiva Deming

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuetiva Deming United States 15 668 631 329 323 222 40 1.3k
Jorge L. Del‐Aguila United States 17 477 0.7× 455 0.7× 369 1.1× 236 0.7× 131 0.6× 25 1.1k
Kevin X. Le United States 11 673 1.0× 588 0.9× 297 0.9× 254 0.8× 74 0.3× 15 1.3k
Irene Piaceri Italy 15 219 0.3× 361 0.6× 282 0.9× 94 0.3× 132 0.6× 42 826
Valeria M. Casadei Italy 6 325 0.5× 499 0.8× 287 0.9× 115 0.4× 92 0.4× 7 824
Samira Parhizkar United States 11 518 0.8× 632 1.0× 285 0.9× 146 0.5× 94 0.4× 16 1.0k
Haeyong Chung United States 9 413 0.6× 667 1.1× 247 0.8× 86 0.3× 141 0.6× 9 916
Grietje Krabbe United States 8 661 1.0× 450 0.7× 206 0.6× 208 0.6× 32 0.1× 8 1.1k
Michael R. Strickland United States 12 324 0.5× 304 0.5× 225 0.7× 127 0.4× 36 0.2× 16 713
Kiyohiro Yamazaki Japan 16 160 0.2× 246 0.4× 282 0.9× 77 0.2× 92 0.4× 43 693
Maricarmen Pachicano United States 4 652 1.0× 483 0.8× 288 0.9× 47 0.1× 183 0.8× 6 1.3k

Countries citing papers authored by Yuetiva Deming

Since Specialization
Citations

This map shows the geographic impact of Yuetiva Deming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuetiva Deming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuetiva Deming more than expected).

Fields of papers citing papers by Yuetiva Deming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuetiva Deming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuetiva Deming. The network helps show where Yuetiva Deming may publish in the future.

Co-authorship network of co-authors of Yuetiva Deming

This figure shows the co-authorship network connecting the top 25 collaborators of Yuetiva Deming. A scholar is included among the top collaborators of Yuetiva Deming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuetiva Deming. Yuetiva Deming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deming, Yuetiva, Sterling C. Johnson, Sanjay Asthana, et al.. (2025). Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study. Molecular Neurodegeneration. 20(1). 109–109. 1 indexed citations
2.
Jonaitis, Erin M., et al.. (2023). Apolipoprotein E moderates the association between non‐APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function. Alzheimer s & Dementia. 20(2). 1063–1075. 5 indexed citations
3.
Hu, Bowen, Burcu F. Darst, Shubhabrata Mukherjee, et al.. (2023). Biobank-wide association scan identifies risk factors for late-onset Alzheimer’s disease and endophenotypes. eLife. 12.
4.
Deming, Yuetiva, Antonio González, Tyler K. Ulland, et al.. (2023). Preclinical Alzheimer’s disease is associated with distinct gut microbial metagenomic profiles. Alzheimer s & Dementia. 19(S14). 1 indexed citations
5.
Deming, Yuetiva, Jiacheng Miao, Carol Van Hulle, et al.. (2023). Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk. Alzheimer s & Dementia. 19(8). 3406–3416. 6 indexed citations
6.
Rubinski, Anna, Anna Dewenter, Nicolai Franzmeier, et al.. (2023). Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner. European Journal of Nuclear Medicine and Molecular Imaging. 51(4). 1035–1049. 4 indexed citations
7.
Panyard, Daniel J., Yuetiva Deming, Erin M. Jonaitis, et al.. (2022). Cerebrospinal Fluid Sphingomyelins in Alzheimer’s Disease, Neurodegeneration, and Neuroinflammation1. Journal of Alzheimer s Disease. 90(2). 667–680. 7 indexed citations
8.
Mahoney, Emily R., Logan Dumitrescu, Vijay K. Ramanan, et al.. (2022). Exploring common genetic contributors to neuroprotection from amyloid pathology. Brain Communications. 4(2). fcac066–fcac066. 5 indexed citations
9.
Ewers, Michael, Gloria Biechele, Marc Suárez‐Calvet, et al.. (2020). Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation. EMBO Molecular Medicine. 12(9). e12308–e12308. 80 indexed citations
10.
Deming, Yuetiva, Qiongshi Lu, Yue Ma, et al.. (2020). Principal components from untargeted CSF metabolomics associated with tau. Alzheimer s & Dementia. 16(S2). 1 indexed citations
11.
Ewers, Michael, Nicolai Franzmeier, Marc Suárez‐Calvet, et al.. (2019). Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease. Science Translational Medicine. 11(507). 201 indexed citations
12.
Suárez‐Calvet, Marc, Estrella Morenas‐Rodríguez, Gernot Kleinberger, et al.. (2019). Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Molecular Neurodegeneration. 14(1). 1–1. 185 indexed citations
13.
Rao, Shuquan, Mahdi Ghani, Zhiyun Guo, et al.. (2018). An APOE -independent cis -eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk. Neurobiology of Aging. 66. 178.e1–178.e8. 14 indexed citations
14.
Fernández, María Victoria, John Budde, Jorge L. Del‐Aguila, et al.. (2018). Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease. Frontiers in Neuroscience. 12. 209–209. 18 indexed citations
15.
Deming, Yuetiva, Kathleen Black, David Carrell, et al.. (2016). Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40. BMC Neurology. 16(1). 217–217. 12 indexed citations
16.
Piccio, Laura, Yuetiva Deming, Jorge L. Del‐Aguila, et al.. (2016). Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathologica. 131(6). 925–933. 262 indexed citations
17.
Jin, Sheng Chih, Bruno A. Benítez, Yuetiva Deming, & Carlos Cruchaga. (2015). Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer’s Disease. Methods in molecular biology. 1303. 299–314. 2 indexed citations
18.
Del‐Aguila, Jorge L., María Victoria Fernández, Jessica A. Jiménez, et al.. (2015). Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European–Americans. Alzheimer s Research & Therapy. 7(1). 73–73. 17 indexed citations
19.
Deming, Yuetiva, Jian Xia, Yefei Cai, et al.. (2015). A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin. Neurobiology of Aging. 37. 208.e1–208.e9. 48 indexed citations
20.
Rodgers, Krista M., Yuetiva Deming, Julie Wieseler, et al.. (2013). Reversal of Established Traumatic Brain Injury-Induced, Anxiety-Like Behavior in Rats after Delayed, Post-Injury Neuroimmune Suppression. Journal of Neurotrauma. 31(5). 487–497. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge L. Del‐Aguila Breakdown of academic impact, for papers by Kevin X. Le Breakdown of academic impact, for papers by Irene Piaceri Breakdown of academic impact, for papers by Valeria M. Casadei Breakdown of academic impact, for papers by Samira Parhizkar Breakdown of academic impact, for papers by Haeyong Chung Breakdown of academic impact, for papers by Grietje Krabbe Breakdown of academic impact, for papers by Michael R. Strickland Breakdown of academic impact, for papers by Kiyohiro Yamazaki Breakdown of academic impact, for papers by Maricarmen Pachicano
Rankless by CCL
2026